Almonds are highly nutritious and one of the world's most popular tree nuts. They are rich in healthy fats, antioxidants, vitamins, and minerals.
A one-ounce serving of almonds contains 3.5 grams of fiber, six grams of protein, 14 grams of fat, nine of which are monounsaturated, 37 percent of vitamin E, 32 percent of manganese and 20 percent of magnesium.
Almonds also contain copper, vitamin B2, and phosphorus.
The magnesium in almonds is the reason why it is recommended for those who have high blood pressure or those who are hypertensive.
If you have high blood pressure and you leave it untreated, it can put you at risk of life-threatening medical conditions like heart attacks, strokes, and kidney failure.
According to studies, there is a link in magnesium deficiency and high blood pressure. It is said that when you correct your magnesium intake, it can lead to lowering your blood pressure.
Thus, health experts have concluded that adding almonds to your diet can help you in controlling your blood pressure.
One other way that almonds can lower your risk for heart attacks and stroke is that it can also lower your cholesterol level. Eating one or two handfuls of almonds a day can help in regulating the level of cholesterol in your blood.
And, almonds have also been cited to lower high levels of blood sugar. It is recommended for diabetic people because it is low in carbohydrates and high in healthy fats, protein, and fiber.
The antioxidants in almonds can help protect the cells in your body from oxidative damage that can lead to inflammation, aging, and diseases like cancer.
And, almonds can also boost your weight loss plan because snacking on this nut can make you feel full, thus can significantly lower your calorie intake. In fact, almonds can be a good addition if you are following the keto diet. Its low carb and high-fat content fit perfectly with the ketogenic diet.
The health benefits of almonds are endless, and these nuts are delicious as well, making it a good addition to your diet for a healthy lifestyle.
Image credit courtesy of HealthAliciousNess/Flickr


Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
FDA Approves Mitapivat for Anemia in Thalassemia Patients
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



